• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性前列腺切除术后病理学家与基于人工智能的分级对转移结局预测的比较

Comparison of Pathologist and Artificial Intelligence-based Grading for Prediction of Metastatic Outcomes After Radical Prostatectomy.

作者信息

Oliveira Lia D, Lu Jiayun, Erak Eric, Mendes Adrianna A, Dairo Oluwademilade, Ertunc Onur, Kulac Ibrahim, Baena-Del Valle Javier A, Jones Tracy, Hicks Jessica L, Glavaris Stephanie, Guner Gunes, Vidal Igor D, Trock Bruce J, Joshi Uttara, Kondragunta Chaith, Bonthu Saikiran, Joshu Corinne, Singhal Nitin, De Marzo Angelo M, Lotan Tamara L

机构信息

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

出版信息

Eur Urol Oncol. 2025 Feb;8(1):9-13. doi: 10.1016/j.euo.2024.08.004. Epub 2024 Sep 3.

DOI:10.1016/j.euo.2024.08.004
PMID:39232875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11841679/
Abstract

Gleason grade group (GG) is the most powerful prognostic variable in localized prostate cancer; however, interobserver variability remains a challenge. Artificial intelligence algorithms applied to histopathologic images standardize grading, but most have been tested only for agreement with pathologist GG, without assessment of performance with respect to oncologic outcomes. We compared deep learning-based and pathologist-based GGs for an association with metastatic outcome in three surgical cohorts comprising 777 unique patients. A digitized whole slide image of the representative hematoxylin and eosin-stained slide of the dominant tumor nodule was assigned a GG by an artificial intelligence-based grading algorithm and was compared with the GG assigned by a contemporary pathologist or the original pathologist-assigned GG for the entire prostatectomy. Harrell's C-indices based on Cox models for time to metastasis were compared. In a combined analysis of all cohorts, the C-index for the artificial intelligence-assigned GG was 0.77 (95% confidence interval [CI]: 0.73-0.81), compared with 0.77 (95% CI: 0.73-0.81) for the pathologist-assigned GG. By comparison, the original pathologist-assigned GG for the entire case had a C-index of 0.78 (95% CI: 0.73-0.82). PATIENT SUMMARY: Artificial intelligence-enabled prostate cancer grading on a single slide was comparable with pathologist grading for predicting metastatic outcome in men treated by radical prostatectomy, enabling equal access to expert grading in lower resource settings.

摘要

Gleason分级组(GG)是局限性前列腺癌中最有力的预后变量;然而,观察者间的变异性仍然是一个挑战。应用于组织病理学图像的人工智能算法使分级标准化,但大多数仅针对与病理学家GG的一致性进行了测试,而未评估其在肿瘤学结果方面的表现。我们在三个包含777例独特患者的手术队列中,比较了基于深度学习的GG和基于病理学家的GG与转移结果的关联。通过基于人工智能的分级算法为优势肿瘤结节的代表性苏木精和伊红染色玻片的数字化全切片图像分配一个GG,并将其与当代病理学家分配的GG或整个前列腺切除术中原病理学家分配的GG进行比较。比较了基于Cox模型的转移时间的Harrell C指数。在所有队列的综合分析中,人工智能分配的GG的C指数为0.77(95%置信区间[CI]:0.73 - 0.81),而病理学家分配的GG的C指数为0.77(95%CI:0.73 - 0.81)。相比之下,整个病例中原病理学家分配的GG的C指数为0.78(95%CI:0.73 - 0.82)。患者总结:在接受根治性前列腺切除术的男性中,基于人工智能的单张玻片前列腺癌分级在预测转移结果方面与病理学家分级相当,从而能够在资源较少的环境中平等获得专家级分级。

相似文献

1
Comparison of Pathologist and Artificial Intelligence-based Grading for Prediction of Metastatic Outcomes After Radical Prostatectomy.根治性前列腺切除术后病理学家与基于人工智能的分级对转移结局预测的比较
Eur Urol Oncol. 2025 Feb;8(1):9-13. doi: 10.1016/j.euo.2024.08.004. Epub 2024 Sep 3.
2
Development and retrospective validation of an artificial intelligence system for diagnostic assessment of prostate biopsies: study protocol.用于前列腺活检诊断评估的人工智能系统的开发与回顾性验证:研究方案
BMJ Open. 2025 Jul 7;15(7):e097591. doi: 10.1136/bmjopen-2024-097591.
3
Variation within and between digital pathology and light microscopy for the diagnosis of histopathology slides: blinded crossover comparison study.数字病理学与光学显微镜检查在组织病理学切片诊断中的内部及相互间差异:双盲交叉对比研究
Health Technol Assess. 2025 Jul;29(30):1-75. doi: 10.3310/SPLK4325.
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
A systematic review and meta-analysis of artificial intelligence diagnostic accuracy in prostate cancer histology identification and grading.人工智能在前列腺癌组织学识别和分级中的诊断准确性的系统评价和荟萃分析。
Prostate Cancer Prostatic Dis. 2023 Dec;26(4):681-692. doi: 10.1038/s41391-023-00673-3. Epub 2023 Apr 25.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Artificial Intelligence-Based Digital Histologic Classifier for Prostate Cancer Risk Stratification: Independent Blinded Validation in Patients Treated With Radical Prostatectomy.基于人工智能的前列腺癌风险分层数字组织学分类器:接受根治性前列腺切除术患者的独立盲法验证
JCO Clin Cancer Inform. 2025 Jun;9:e2400292. doi: 10.1200/CCI-24-00292. Epub 2025 Jun 18.
8
Artificial intelligence for diagnosing exudative age-related macular degeneration.人工智能在渗出性年龄相关性黄斑变性诊断中的应用。
Cochrane Database Syst Rev. 2024 Oct 17;10(10):CD015522. doi: 10.1002/14651858.CD015522.pub2.
9
Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma.病理学家解读与人工智能驱动的黑色素瘤肿瘤浸润淋巴细胞评估
JAMA Netw Open. 2025 Jul 1;8(7):e2518906. doi: 10.1001/jamanetworkopen.2025.18906.
10
An artificial intelligence model for nuclear grading of clear cell renal cell carcinoma using whole slide images: a retrospective, multicenter, diagnostic study.一种使用全切片图像对透明细胞肾细胞癌进行核分级的人工智能模型:一项回顾性、多中心诊断研究。
Int J Surg. 2025 Jul 1;111(7):4400-4411. doi: 10.1097/JS9.0000000000002484. Epub 2025 May 12.

引用本文的文献

1
From Algorithms to Insight: The Transformative Power of Artificial Intelligence and Machine Learning in Urological Cancer Research.从算法到洞察:人工智能和机器学习在泌尿生殖系统癌症研究中的变革力量。
Curr Oncol. 2025 May 14;32(5):277. doi: 10.3390/curroncol32050277.
2
Clinical implications of deep learning based image analysis of whole radical prostatectomy specimens.基于深度学习的根治性前列腺切除术标本图像分析的临床意义
Sci Rep. 2025 Mar 31;15(1):11006. doi: 10.1038/s41598-025-95267-5.

本文引用的文献

1
Predicting Prostate Cancer Molecular Subtype With Deep Learning on Histopathologic Images.基于病理图像深度学习预测前列腺癌分子亚型。
Mod Pathol. 2023 Oct;36(10):100247. doi: 10.1016/j.modpat.2023.100247. Epub 2023 Jun 10.
2
A deep learning system for prostate cancer diagnosis and grading in whole slide images of core needle biopsies.深度学习系统在核心针活检的全切片图像中用于前列腺癌的诊断和分级。
Sci Rep. 2022 Mar 1;12(1):3383. doi: 10.1038/s41598-022-07217-0.
3
Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge.
人工智能在前列腺癌诊断和 Gleason 分级中的应用:PANDA 挑战赛。
Nat Med. 2022 Jan;28(1):154-163. doi: 10.1038/s41591-021-01620-2. Epub 2022 Jan 13.
4
Evaluation of artificial intelligence on a reference standard based on subjective interpretation.基于主观解读的参考标准对人工智能的评估。
Lancet Digit Health. 2021 Nov;3(11):e693-e695. doi: 10.1016/S2589-7500(21)00216-8. Epub 2021 Sep 21.
5
Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens.从活检标本中开发和验证用于前列腺癌 Gleason 分级的深度学习算法。
JAMA Oncol. 2020 Sep 1;6(9):1372-1380. doi: 10.1001/jamaoncol.2020.2485.
6
The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.2019 年泌尿生殖系统病理学学会(GUPS)关于当代前列腺癌分级的白皮书。
Arch Pathol Lab Med. 2021 Apr 1;145(4):461-493. doi: 10.5858/arpa.2020-0015-RA.
7
Comparison of Artificial Intelligence Techniques to Evaluate Performance of a Classifier for Automatic Grading of Prostate Cancer From Digitized Histopathologic Images.比较人工智能技术评估分类器在从数字化组织病理学图像自动分级前列腺癌方面的性能。
JAMA Netw Open. 2019 Mar 1;2(3):e190442. doi: 10.1001/jamanetworkopen.2019.0442.
8
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.一种当代前列腺癌分级系统:格里森评分的有效替代方案。
Eur Urol. 2016 Mar;69(3):428-35. doi: 10.1016/j.eururo.2015.06.046. Epub 2015 Jul 10.
9
Phase 3 study of adjuvant radiotherapy versus wait and see in pT3 prostate cancer: impact of pathology review on analysis.pT3 期前列腺癌辅助放疗与观察等待的 3 期研究:病理复查对分析的影响。
Eur Urol. 2013 Aug;64(2):193-8. doi: 10.1016/j.eururo.2013.03.029. Epub 2013 Mar 17.
10
Standardization of Gleason grading among 337 European pathologists.337 位欧洲病理学家之间的 Gleason 分级标准化。
Histopathology. 2013 Jan;62(2):247-56. doi: 10.1111/his.12008.